Cargando…

A novel immune prognostic index for stratification of high-risk patients with early breast cancer

The prognostic value of current multigene assays for breast cancer is limited to hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer. Despite the prognostic significance of immune response-related genes in breast cancer, immune gene signatures have not be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hannah, Kwon, Mi Jeong, Koo, Beom-Mo, Park, Hee Geon, Han, Jinil, Shin, Young Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794340/ https://www.ncbi.nlm.nih.gov/pubmed/33420250 http://dx.doi.org/10.1038/s41598-020-80274-5

Ejemplares similares

A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
por: Gong, Gyungyub, et al.
Publicado: (2017)

MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer
por: Han, Jinil, et al.
Publicado: (2017)

Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2− Early Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2021)

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2019)

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2015)

Body Mass Index with Tumor (18)F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer
por: Hyun, Seung Hyup, et al.
Publicado: (2016)

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
por: Hong, Junshik, et al.
Publicado: (2017)

UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer
por: Kim, Yu-Jin, et al.
Publicado: (2020)

High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy
por: Na, Hyelin, et al.
Publicado: (2019)

Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies with Clinical Risk Stratification
por: Cho, Hee Won, et al.
Publicado: (2022)

BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2018)

A hierarchical prognostic model for risk stratification in patients with early breast cancer according to (18)F‐fludeoxyglucose uptake and clinicopathological parameters
por: Cha, Jongtae, et al.
Publicado: (2018)

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
por: Loi, Sherene, et al.
Publicado: (2022)

Comparison of three risk stratification scores in gastroschisis neonates: gastroschisis prognostic score, gastroschisis risk stratification index and complex gastroschisis
por: Tauriainen, Asta, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients
por: Blank, Patricia R., et al.
Publicado: (2014)

Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
por: Jeong, Hasong, et al.
Publicado: (2019)

A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age
por: Kwon, Jeanny, et al.
Publicado: (2017)

Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients
por: Jeong, Hae Min, et al.
Publicado: (2017)

Actionable Gene Expression-Based Patient Stratification for Molecular Targeted Therapy in Hepatocellular Carcinoma
por: Kwon, Jung-Hee, et al.
Publicado: (2013)

Diversity index as a novel prognostic factor in breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2017)

Risk stratification for disease progression in pT3 prostate cancer after robot-assisted radical prostatectomy
por: Hong, Jeong Hee, et al.
Publicado: (2017)

The multidimensional prognostic index (MPI) for the prognostic stratification of older inpatients with COVID-19: A multicenter prospective observational cohort study
por: Pilotto, Alberto, et al.
Publicado: (2021)

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas
por: Duregon, Eleonora, et al.
Publicado: (2016)

Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia
por: Giudice, Valentina, et al.
Publicado: (2022)

Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer
por: Liu, Jingxin, et al.
Publicado: (2019)

Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer
por: Yao, Yan, et al.
Publicado: (2022)

Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2011)

Regulation of Ovarian Cancer Stem Cells or Tumor-Initiating Cells
por: Kwon, Mi Jeong, et al.
Publicado: (2013)

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma
por: Zhai, Xinyu, et al.
Publicado: (2023)

Deciphering the Molecular Profile of Lung Cancer: New Strategies for the Early Detection and Prognostic Stratification
por: Dama, Elisa, et al.
Publicado: (2019)

Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer
por: Boscolo, Alice, et al.
Publicado: (2020)

Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients
por: García, Patricia, et al.
Publicado: (2020)

Early Prognostic Stratification of Clostridioides difficile Infection in the Emergency Department: The Role of Age and Comorbidities
por: Covino, Marcello, et al.
Publicado: (2022)

Immunological Classification of Pancreatic Carcinomas to Identify Immune Index and Provide a Strategy for Patient Stratification
por: Chen, Yi, et al.
Publicado: (2022)

Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2022)

Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification
por: Olsen, Maria, et al.
Publicado: (2021)

Prognostic value of systemic immune inflammation index and geriatric nutrition risk index in early-onset colorectal cancer
por: Xiang, Shuai, et al.
Publicado: (2023)

Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels
por: Kim, Hyung-Don, et al.
Publicado: (2021)

A Novel Prognostic Index for Metastatic Colon Cancer: The Prognostic Immune Nutritional Index
por: Kayikcioglu, Erkan, et al.
Publicado: (2023)

Impact of vertical stratification on the 2020 spring bloom in the Yellow Sea
por: Kim, Go-Un, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1j7ijdeg015qbo142a242r60ge